FDA’s Warning Letter Database now screens for COVID-19 Violations 

Posted by Joe Stefansky on May 11, 2020 in Alert, Industry News,

A public facing FDA Warning Letter Database exists regarding manufacturers that commit violations of U.S. Food and Drug Administration (FDA) regulations. Recently, this database began flagging organizations for COVID-19 related violations. Specifically, this database captures warning letters that the FDA previously sent out to implicated manufacturers. Issues that trigger a warning letter may include poor manufacturing practices, false product claims, or inaccurate directions for the use of a product.

Streamline Verify has been screening clients against this database and would like to draw attention to the FDA’s guidance to avoid COVID19-related violations in their new COVID-19 pages: Frequently Asked Questions and  Guidance Documents for Industry, FDA Staff and Other Stakeholders.

Notably, a new issue coming up repeatedly in the database’s subject header is related to Health Fraud, namely Unapproved and Misbranded Products Related to Coronavirus Disease 2019. Some products are misbranded drugs under section 502 of the FD&C Act, 21 U.S.C. § 352.  Others are violating the introduction of products into interstate commerce is prohibited under sections 301(a) and (d) of the FD&C Act, 21 U.S.C. § 331(a) and (d).

As of today, the FDA Warnings Letter Database has excluded 51 entities due to a COVID-19 related concern. A required correction plan with directions and time frames are included in letter.

There is a lag time and the letter in the database may not be a timely reflection of the current regulatory status of the letter recipient. Upon notation from the manufacturer of the corrective actions, next the FDA will confirm the corrections made are sufficient. The letters may not contain regulatory information between the FDA and the letter recipient that occurred subsequently to the letter’s original sent date.

For more information about this database or FDA agency records, please see the page How to Make a Freedom of Information Act (FOIA) Request. As of 3/12/2020, to ensure timely logging, the FDA is asking that all requests be made via their online portal rather than by mail, fax, or courier.

About Joe Stefansky

About Joe Stefansky

Joe Stefansky has a keen sense of business opportunities in complex problems, using technology to transform difficulty into efficiency. The CEO and founder of Streamline Verify specializes in solving compliance, legal and administrative issues through intuitively designed software that reduces costs and saves time.

Related Articles

Regards from HCCA’s 19th Annual ...

April 21, 2015

The HCCA's 19th Annual Compliance Institute is keeping us pretty busy!  Here are a couple of eye-openers from the experience: There's a lot to learn.  Compliance law is constantly changing.  Ke...

Infographic: 2017 OIG Exclusions & Penalties

December 20, 2017

In 2017, the HHS Office of the Inspector General (OIG) remained active in detecting Medicare and Medicaid provider violations, resulting in fines or settlements and exclusions from participation. Ther...

Self Disclosure – The Kroger Story

August 8, 2016

  Kroger Asked to Shell Out $21,523,047 for allegedly violating the Civil Monetary Penalties Law In December last year, retail food chain Kroger, headquartered in Cincinnati, Ohio, agreed to pa...